TY  - JOUR 
AU  - Crittenden, Jill R
AU  - Cantuti Castelvetri, Ippolita
AU  - Saka, Esen
AU  - Keller-McGandy, Christine E
AU  - F. Hernandez, Ledia
AU  - Kett, Lauren E.
AU  - Young, Anne B
AU  - Standaert, David G
AU  - Graybiel, Ann M
PY  - 2009
SN  - 0027-8424
UR  - http://hdl.handle.net/20.500.12020/1220
AB  - Voluntary movement difficulties in Parkinson's disease are initially relieved by l-DOPA therapy, but with disease progression, the repeated l-DOPA treatments can produce debilitating motor abnormalities known as l-DOPA-induced dyskinesias. We show...
LA  - en
PB  - National Academy of Sciences
TI  - Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy.
DO  - https://doi.org/10.1073/pnas.0812822106
T2  - Proceedings of the National Academy of Sciences (PNAS)
M2  - 2892
KW  - ERK
KW  - L-DOPA
KW  - Parkinson’s disease
KW  - Striatum
KW  - Dyskinesia
VL  - 106
ER  -